Resectoscopic surgery may be an alternative to hysterectomy in high-risk women with atypical endometrial hyperplasia

Journal of Minimally Invasive Gynecology

Volumn 14, Issue 1, 2007, Pages 68-73

  Edris, Fawaz ^a   Vilos, George A ^a   AL Mubarak, Awatif ^a   Ettler, Helen C ^a   Hollett Caines, Jackie ^a   Abu Rafea, Basim ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Abnormal uterine bleeding; Atypia; Endometrial hyperplasia; Hysteroscopy; Resectoscopic surgery

Indexed keywords

ADULT; AGE; AGED; AMENORRHEA; ARTICLE; ATYPICAL ENDOMETRIAL HYPERPLASIA; BODY MASS; CAUSE OF DEATH; COHORT ANALYSIS; COLON CANCER; ELECTROCOAGULATION; ENDOMETRIUM CANCER; ENDOMETRIUM HYPERPLASIA; ENDOSCOPIC SURGERY; EVALUATION; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; HYSTERECTOMY; HYSTEROSCOPY; INTERMETHOD COMPARISON; LUNG CANCER; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; OUTCOME ASSESSMENT; PARITY; PATIENT COMPLIANCE; PROSPECTIVE STUDY; RESECTOSCOPIC SURGERY; SALPINGOOOPHORECTOMY; TEACHING HOSPITAL; TREATMENT INDICATION; UTERUS BLEEDING; UTERUS SURGERY;

ADULT; AGED; BIOPSY; COHORT STUDIES; ELECTROCOAGULATION; ENDOMETRIAL HYPERPLASIA; FEMALE; HUMANS; HYSTERECTOMY; HYSTEROSCOPY; METRORRHAGIA; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33845965372     PISSN: 15534650     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmig.2006.08.007     Document Type: Article

References (27)

1. Kurman R.J., and Norris H.J. Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well-differentiated carcinoma. Cancer 49 (1982) 2547-2559
2. Kurman R.J., Kaminski P.F., and Norris H.J. The behavior of endometrial hyperplasia: a long-term study of "untreated" hyperplasia in 170 patients. Cancer 56 (1985) 403-412
3. Ferenczy A., and Gelfand M. The biologic significance of cytologic atypia in progestogen-treated endometrial hyperplasia. Am J Obstet Gynecol 160 (1989) 126-131
4. Silverberg S.G., and Kurman R.J. Endometrial polyps and hyperplasias. In: Rosai J. (Ed). Tumors of the Uterine Corpus and Gestational Trophoblastic Disease (1992), Armed Forces Institute of Pathology, Washington, D.C 315-345
5. Hallberg L., Hogdahl A.M., Nilsson L., and Rybo G. Menstrual blood loss: a population study-variation at different ages and attempts to define normality. Acta Obstet Gynecol Scand 45 (1966) 320-351
6. Shapley M., Jordan K., and Croft P.R. An epidemiological survey of symptoms of menstrual loss in the community. Br J Gen Pract 54 (2004) 359-363
7. MacKenzie I.Z., and Bibby J.G. Critical assessment of dilatation and curettage in 1029 women. Lancet 2 (1978) 566-568
8. Koss L.G., Schreiber K., Oberlander S.G., Moussouris H.F., and Lesser M. Detection of endometrial carcinoma and hyperplasia in asymptomatic women. Obstet Gynecol 64 (1984) 1-11
9. Ash S.J., Farrell S.A., and Flowerdew G. Endometrial biopsy in DUB. J Reprod Med 41 (1996) 892-896
10. Vercellini P., Cortesi I., Oldani S., Moschetta M., De Giorgi O., and Crosignani P.G. The role of transvaginal ultrasonography and outpatient diagnostic hysteroscopy in the evaluation of patients with menorrhagia. Hum Reprod 12 (1997) 1768-1771
11. Farrell S.C., Sampson S.L., and Ash S. Risk categories for abnormal endometrial biopsy in dysfunctional uterine bleeding. J Obstet Gynecol Can 22 (2000) 935-941
12. Spencer C.P., and Whitehead M.I. Endometrial assessment re-visited. (Review). Br J Obstet Gynaecol 106 (1999) 623-632
13. Vilos G.A. Hysteroscopic and nonhysteroscopic endometrial ablation. Obstet Gynecol Clin North Am 31 (2004) 687-704 xi
14. Vilos G.A., Lefebvre G., and Graves G.R. Guidelines for the management of abnormal uterine bleeding: Society of Obstetrics and Gynaecology of Canada (SOGC) Clinical Practice Guidelines. J Obstet Gynaecol Can 23 (2001) 704-709
15. Farquhar C.M., Lethaby A., Sowter M., Verry J., and Baranyai J. An evaluation of risk factors for endometrial hyperplasia in premenopausal women with abnormal menstrual bleeding. Am J Obstet Gynecol 181 (1999) 525-529
16. Orr J.J., Chamberlain D., Kilgone L., and Naumann W. Management of endometrial cancer. American College of Obstetricians and Gynecologists (ACOG) Practice Bulletin Number 65. Obstet Gynecol 106 (2005) 413-425 August 2005
17. Vilos G.A., Harding P.G., and Ettler H.C. Resectoscopic surgery in 10 women with abnormal uterine bleeding and atypical endometrial hyperplasia. J Am Assoc Gynecol Laparosc 9 (2002) 138-144
18. Huang S.J., Amparo E., and Fu Y.S. Histologic classification and behavior of endometrial hyperplasia. Surg Pathol 23 (1988) 223-230
19. Baak J.P., Wisse-Brekelmans E.C., Fleege J.C., van der Putten H.W., and Bezemer P.D. Assessment of the risk of endometrial cancer in hyperplasia, by means of morphological and morphometrical features. Pathol Res Pract 188 (1992) 856-859
20. Terakawa N., Kigawa J., Taketani Y., et al. The behavior of endometrial hyperplasia: a prospective study-Endometrial Hyperplasia Study Group. J Obstet Gynaecol Res 23 (1997) 223-230
21. Horn L.C., Schnurrbusch U., Bilek K., Hentschel B., and Einenkel J. Risk of progression in complex and atypical endometrial hyperplasia: clinicopathologic analysis in cases with and without progestogen treatment. Int J Gynecol Cancer 14 (2004) 348-353
22. Tavassoli F., and Kraus F.T. Endometrial lesions in uteri resected for atypical endometrial hyperplasia. Am J Clin Pathol 70 (1978) 770-779
23. Janicek M.F., and Rosenshein N.B. Invasive endometrial cancer in uteri resected for atypical endometrial hyperplasia. Gynecol Oncol 52 (1994) 373-378
24. Widra E.A., Dunton C.J., McHugh M., and Palazzo J.P. Endometrial hyperplasia and the risk of carcinoma. Int J Gynecol Cancer 5 (1995) 233-235
25. Trimble C.L. Atypical endometrial hyperplasia: a tough call. Int J Gynecol Cancer 15 (2005) 401
26. Beutler H.K., Dockerty M.B., and Randall L.M. Precancerous lesions of the endometrium. Am J Obstet Gynecol 86 (1963) 433-443
27. Welch W.R., and Scully R.E. Precancerous lesions of the endometrium. Hum Pathol 8 (1997) 503-512